• Triazole ALDH2 Activators for Myocardial Ischemia

  2026-10-07

  The reference study reports a triazole-based series of aldehyde dehydrogenase 2 (ALDH2) activators designed to improve both enzyme activation and water solubility. Its lead compound, Z17, showed strong ALDH2 activation and improved cardiac and biochemical outcomes in a mouse ischemia–reperfusion model, supporting further preclinical investigation while leaving clinical translation and safety unanswered.

• ACSL4, β-Oxidation, and Endometrial Decidualization

  2026-10-07

  A 2024 Molecular Metabolism study identifies ACSL4-driven fatty acid β-oxidation, rather than lipid droplet accumulation itself, as a functional metabolic pathway supporting endometrial decidualization. By combining human and mouse tissue analysis with cellular perturbation and implantation models, the study links lipid utilization to uterine receptivity while defining important limits for translation.

• URB597 and the Translational Future of FAAH Biology

  2026-10-06

  URB597, also known as KDS-4103, offers a selective way to interrogate FAAH biology and endocannabinoid signaling without treating cannabidiol’s broader pharmacology as a single mechanism. This thought-leadership analysis connects a 2026 mouse study of cannabidiol in inflammatory pain with a translational framework for neuroplasticity, neuroinflammation, and pain research while defining the evidence boundaries that still separate mechanistic promise from clinical validation.

• Erastin and Ferroptosis: Evidence, Uses, Limits

  2026-10-06

  Erastin is a widely used small-molecule ferroptosis inducer for studying cystine metabolism, glutathione defense, lipid peroxidation and redox-dependent cancer-cell vulnerabilities. Its strongest value is as a mechanistic research probe, while genotype selectivity, direct target assignment and translation beyond controlled cell models remain important limitations.

• Endothelial SGK1 and Vascular Stiffening

  2026-10-05

  Zhang and colleagues identify endothelial SGK1 as a mechanistic link between mineralocorticoid and salt-sensitive signaling, actin remodeling, and vascular stiffening. Genetic deletion and pharmacological inhibition produced convergent evidence across mouse, ex vivo, and human endothelial-cell models, while the findings remain preclinical and do not establish clinical efficacy.

• γH2AX DNA Damage Detection: Five Evidence Questions

  2026-10-05

  A source-grounded guide to what γ-H2AX immunofluorescence can show, how strong the current FLASH-RT evidence is, and where interpretation must remain cautious.

• Medroxyprogesterone Acetate: Receptor to Translation

  2026-10-04

  A thought-leadership analysis of Medroxyprogesterone acetate as a context-dependent research tool, connecting progesterone signaling with endometrial lipid metabolism, renal epithelial biology, neurobiology, and translational study design.

• E-64d: Interpreting Protease-Driven Cell States

  2026-10-03

  E-64d is a membrane-permeable cysteine protease inhibitor whose broad intracellular activity can help frame causal questions in apoptosis, platelet biology, neuroprotection, and cancer research. This article connects its pharmacology with new findings on GA-driven autophagic degradation of DELLA proteins while defining the limits of cross-system interpretation.

• Sumatriptan’s Anti-Inflammatory Evidence

  2026-10-01

  This systematic review reframes Sumatriptan Succinate as more than an acute migraine medicine by integrating evidence for cytokine, NF-κB, nitric oxide, caspase, and CGRP regulation across inflammatory injury models. Its main practical value is hypothesis generation: receptor-centered experiments can test whether 5-HT1B/1D signaling contributes to tissue protection beyond trigeminovascular effects.

• Homoharringtonine: Mechanism and Research Evidence

  2026-10-01

  Homoharringtonine is a cytotoxic alkaloid and protein synthesis inhibitor used in leukemia research and cancer biology. Peer-reviewed evidence also supports SARS-CoV-2 antiviral research, but antiviral findings remain distinct from an approved self-treatment or a validated clinical protocol.

• Vitamin D/VDR Control of Endometrial Decidualization

  2026-09-30

  This study shows that active vitamin D promotes human endometrial stromal cell decidualization through VDR-dependent regulation of CYP19, ESR1, and the local estrogen environment. Its combination of time-course analysis, VDR perturbation, primary-cell validation, and ChIP-qPCR provides a mechanistic framework for understanding how vitamin D status may influence endometrial receptivity.

• Acifran Workflows for HCAR Lipid Signaling

  2026-09-30

  Build reproducible HCAR2/HCAR3 experiments with Acifran by linking receptor activation to cAMP and lipid-metabolism phenotypes. This workflow emphasizes matched receptor controls, solvent discipline, and structure-informed interpretation rather than assuming that one agonist produces identical signaling in every cell context.

• Bafilomycin A1: Designing Better Mitophagy Assays

  2026-09-29

  Bafilomycin A1 is a powerful V-ATPase inhibitor, but interpreting mitophagy experiments requires separating increased autophagic cargo from impaired lysosomal clearance. This guide connects its pharmacology with the BipD–KLHL9/KLHL13/CUL3–IMMT pathway in bacterial infection and provides an assay-focused workflow.

• HotStart™ 2X Green qPCR Master Mix Guide

  2026-09-29

  This practical guide explains how HotStart™ 2X Green qPCR Master Mix supports SYBR Green detection for cDNA and DNA quantification while reducing nonspecific amplification risks associated with reaction setup. It is appropriate for real-time PCR gene expression analysis, RNA-seq validation, and nucleic acid quantification, but it should not be treated as a direct RNA assay or used without instrument- and target-specific validation.

• Meropenem Workflows for Infection Research

  2026-09-28

  Meropenem supports controlled antibacterial, cell-culture, and Gram-negative infection-model experiments when concentration, solvent, and resistance context are documented. This guide converts its PBP-directed activity into reproducible workflows while showing where broad activity should not be confused with efficacy against carbapenem-resistant isolates.

8664 records 1/578 page Next 12345 下5页 Last page